Navigation Links
IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
Date:3/3/2009

MOUNTAIN VIEW, Calif., March 3 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its fourth quarter and full year 2008 financial results after the market closes on Tuesday, March 10, 2009. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, March 10, 2009 to discuss the results of the quarter and full year and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 366-8058 U.S. or (303) 262-2190 (International), or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Tuesday, March 10, 2009 through Tuesday, March 17, 2009 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11127343#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com.


'/>"/>
SOURCE IRIDEX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Reports Third Quarter 2008 Financial Results
2. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
3. IRIDEX Reports First Quarter 2008 Financial Results
4. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
5. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
6. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
7. IRIDEX Reports Third Quarter Financial Results
8. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
9. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
10. James B. Hawkins Appointed to IRIDEX Board of Directors
11. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... , ... June 23, 2017 , ... MD Now ... This is MD Now’s 28th facility overall and marks the urgent care center's eighth ... one mile North of The Falls shopping mall. The new clinic offers a wide ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ... the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people ... the Biggert-Waters Act was enacted to reflect the actual risk in flood zone ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... assistance and financial planning services to communities in the greater Chicago metropolitan area, ... to offer assistance to underprivileged youth in Chicago. , Founded in 1897, Hephzibah ...
(Date:6/23/2017)... Morgantown, WV (PRWEB) , ... June 23, 2017 ... ... asset protection services and personal financial planning to families and business owners in ... Stepping Stones organization to help provide services to differently abled residents in the ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: